USPTO trademark

SYMSFYRE

RegisteredUSPTOWord markClass 5

"SYMSFYRE" is a word mark owned by AstraZeneca AB, filed at the USPTO on May 12, 2022. It is registered and covers class 5 (Pharmaceuticals).

View AstraZeneca AB portfolioGet this data via the API
Official USPTO record
SYMSFYRE trademark as filed
As filed with the USPTO
Status
Registered
Since February 4, 2025
Filed
May 12, 2022
Registered
February 4, 2025
Priority date
May 10, 2022
Claimed from European Union
Application no.
97408277
Registration no.
7674661
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns SYMSFYRE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

AstraZeneca AB

Södertälje, Sweden

6,107 trademarks in the portfolioView company

Representative

Cara M. Kearney

Astrazeneca Pharmaceuticals LP

Goods and services

What the mark covers

The products and services SYMSFYRE is filed for, grouped by Nice class.

  • Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. 1(b) basis deleted; proceed to registration
  4. Notice of allowance cancelled
  5. Teas delete 1(b) basis received
  6. Notice of approval of extension request e-mailed
  7. Sou extension 1 granted
  8. Sou extension 1 filed
  9. Sou teas extension received
  10. Noa e-mailed - sou required from applicant

10 earlier steps on the official record.

FAQ

About SYMSFYRE

Who owns the trademark "SYMSFYRE"?

The USPTO trademark "SYMSFYRE" (application 97408277) is owned by AstraZeneca AB.

What is the status of "SYMSFYRE"?

Its status at the USPTO is: registered.

When was "SYMSFYRE" registered?

It was registered on February 4, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SYMSFYRE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2a8a-8994-773a-8ae1-b0a377993eb3
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2a8a-8994-773a-8ae1-b0a377993eb3",
  "object": "trademark",
  "mark_text": "SYMSFYRE",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97408277",
  "filing_date": "2022-05-12",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "AstraZeneca AB",
      "entity_id": "ent_019eb700-571d-718e-bf3d-80fe37712629"
    }
  ]
}